LGE Extent (% Myocardium Scarred) Calculator

Clinical calculation support · Verify results before clinical use

Calculate myocardial scar burden

Enter scar mass and total left ventricular myocardial mass from cardiac MRI analysis.

g
Total myocardial scar mass quantified on LGE images.
g
Total left ventricular myocardial mass measured using the same analysis approach.
— Percent
LGE extent (% of LV mass)
Enter values to calculate

LGE extent = (scar mass ÷ total LV myocardial mass) × 100.

Clinical context

The percentage quantifies the proportion of LV myocardial mass classified as LGE. Interpret it in the context of the underlying disease and the CMR quantification method.

About LGE extent

Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is used to characterize myocardial injury and replacement fibrosis. LGE extent can be expressed as the mass of LGE tissue relative to total LV myocardial mass.

Calculation: LGE extent (%) = (total scar mass [g] ÷ total LV myocardial mass [g]) × 100.

How to interpret the result

  • The result is a quantitative proportion, not a stand-alone diagnosis or a universal risk category.
  • Quantification can vary according to the analysis method, including manual planimetry, signal-intensity threshold methods, and full-width-at-half-maximum methods.
  • In hypertrophic cardiomyopathy (HCM), LGE involving approximately 15% or more of LV mass has been used as a marker of extensive LGE in sudden cardiac death risk assessment. This threshold is disease-specific and should not be generalized to all cardiac conditions.
  • There is no universal “normal” LGE percentage that applies to every disease, CMR protocol, and quantification method.

Practical checks

  • Use scar mass and total LV myocardial mass measured from the same study and compatible quantification approach.
  • Scar mass must be non-negative and should not exceed total LV myocardial mass.
  • A zero or missing total LV myocardial mass prevents calculation.

References

Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 1999;343:1445–1453. doi:10.1056/NEJM199911183432003
Standardized image interpretation and post-processing in cardiovascular magnetic resonance: 2020 update. Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post-Processing. Full text
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy. Ommen SR, Ho CY, Asif IM, et al. J Am Coll Cardiol. 2024. doi:10.1016/j.jacc.2024.02.014
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. Full text